Design, Synthesis and Preclinical Assessment of 99mTc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging
Authors:
- Diana Trujillo-BenítezDTDiana Trujillo-Benítez
- Myrna Luna-GutiérrezMLMyrna Luna-Gutiérrez
- Guillermina Ferro-FloresGuillermina Ferro-Flores
- Blanca Ocampo-GarcíaBlanca Ocampo-García
- Clara Santos-CuevasCSClara Santos-Cuevas
- Gerardo Bravo-VillegasGBGerardo Bravo-Villegas
- Enrique Morales-ÁvilaEnrique Morales-Ávila
- Pedro Cruz-NovaPCPedro Cruz-Nova
- Lorenza Díaz-NietoLorenza Díaz-Nieto
- Janice García-QuirozJGJanice García-Quiroz
- Erika Azorín-VegaErika Azorín-Vega
- Antonio RosatoARAntonio Rosato
Open Access
Abstract
Fibroblast activation protein (FAP) is expressed in the microenvironment of most human epithelial tumors. 68Ga-labeled FAP inhibitors based on the cyanopyrrolidine structure (FAPI) are currently used for the detection of the tumor microenvironment by PET imaging. This research aimed to design, synthesize and preclinically evaluate a new FAP inhibitor radiopharmaceutical based on the 99mTc-((R)-1-((6-hydrazinylnicotinoyl)-D-alanyl) pyrrolidin-2-yl) boronic acid (99mTc-iFAP) structure for SPECT imaging. Molecular docking for affinity calculations was performed using the AutoDock software. The chemical synthesis was based on a series of coupling reactions of 6-hidrazinylnicotinic acid (HYNIC) and D-alanine to a boronic acid derivative. The iFAP was prepared as a lyophilized formulation based on EDDA/SnCl2 for labeling with 99mTc. The radiochemical purity (R.P.) was verified via ITLC-SG and reversed-phase radio-HPLC. The stability in human serum was evaluated by size-exclusion HPLC. In vitro cell uptake was assessed using N30 stromal endometrial cells (FAP positive) and human fibroblasts (FAP negative). Biodistribution and tumor uptake were determined in Hep-G2 tumor-bearing nude mice, from which images were acquired using a micro-SPECT/CT. The iFAP ligand (Ki = 0.536 nm, AutoDock affinity), characterized by UV-Vis, FT-IR, 1H–NMR and UPLC-mass spectroscopies, was synthesized with a chemical purity of 92%. The 99mTc-iFAP was obtained with a R.P. >98%. In vitro and in vivo studies indicated high radiotracer stability in human serum (>95% at 24 h), specific recognition for FAP, high tumor uptake (7.05 ± 1.13% ID/g at 30 min) and fast kidney elimination. The results found in this research justify additional dosimetric and clinical studies to establish the sensitivity and specificity of the 99mTc-iFAP.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (314923)
This publication has 33 references indexed in Scilit:
- An experimental and theoretical investigation of Acenaphthene-5-boronic acid: Conformational study, NBO and NLO analysis, molecular structure and FT-IR, FT-Raman, NMR and UV spectraSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2013
- Identification of Selective and Potent Inhibitors of Fibroblast Activation Protein and Prolyl OligopeptidaseJournal of Medicinal Chemistry, 2013
- Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine ScaffoldACS Medicinal Chemistry Letters, 2013
- 99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In VivoJournal of Nuclear Medicine, 2009
- Synthesis and structure–activity relationship of N-acyl-Gly-, N-acyl-Sar- and N-blocked-boroPro inhibitors of FAP, DPP4, and POPBioorganic & Medicinal Chemistry Letters, 2007
- 99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Biokinetics and dosimetry in patients of 99mTc-EDDA/HYNIC-Tyr3-octreotide prepared from lyophilized kitsApplied Radiation and Isotopes, 2006
- Selective Inhibition of Fibroblast Activation Protein Protease Based on Dipeptide Substrate SpecificityJournal of Biological Chemistry, 2006
- Structural and Kinetic Analysis of the Substrate Specificity of Human Fibroblast Activation Protein αJournal of Biological Chemistry, 2005
- Structure−Activity Relationships of Boronic Acid Inhibitors of Dipeptidyl Peptidase IV. 1. Variation of the P2Position of Xaa-boroPro DipeptidesJournal of Medicinal Chemistry, 1996